Stephen D. Griffin - President and CEO, Director at Anika Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
ANIK on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen D. Griffin since 12 Mar 2025

Holdings reported by Stephen D. Griffin for Anika Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 130,402 $297,072 $15.91 01 Feb 2026 Direct Common Stock
Common Stock 10,671 $102,549 $9.61 01 Feb 2026 Direct
Stock Appreciation Rights 310,207 01 Feb 2026 Direct Common Stock

Transactions reported by Stephen D. Griffin for Anika Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.